Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

被引：0
|
作者：
Pirker, R
Jaeger, U
Pohl, G
Stranzl, T
Simonitsch, I
Kaider, A
Skrabs, C
Filipits, M
机构：
[1] Univ Vienna, Dept Internal Med 1, Vienna, Austria
[2] Univ Vienna, Inst Clin Pathol, Vienna, Austria
[3] Univ Vienna, Dept Med Comp Sci, Vienna, Austria
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
528
引用
收藏
页码：126A / 126A
页数：1
相关论文
共 50 条
  • [31] Constitutively activation of STAT3 is a prognostic factor in activated B-cell subtype of diffuse large B-cell lymphoma
    Huang, Xin
    Cao, Wenfeng
    Igbal, Javeed
    Meng, Bin
    Ding, B. Belinda
    Bi, Chengfeng
    Jiang, Chunsun
    Ye, B. Hilda
    Chan, Wing C.
    Fu, Kai
    CANCER RESEARCH, 2012, 72
  • [32] Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas
    Bai, M
    Tsanou, E
    Agnantis, NJ
    Chaidos, A
    Dimou, D
    Skyrias, A
    Dimou, S
    Vlychou, M
    Galani, V
    Kanavaros, P
    HISTOLOGY AND HISTOPATHOLOGY, 2003, 18 (02) : 449 - 457
  • [33] Survival outcomes in primary orbital diffuse large B-cell lymphoma.
    Baidoun, Firas
    Hoppe, Bradford S.
    Tun, Han W.
    Moustafa, Muhamad Alhaj
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] PKCβ:: A rational therapeutic target in diffuse large B-cell lymphoma.
    Wu, EX
    Aguiar, RCT
    Savage, KJ
    Kutok, JL
    Wang, FF
    Aster, JC
    Shipp, MA
    BLOOD, 2002, 100 (11) : 202A - 202A
  • [35] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma.
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    MODERN PATHOLOGY, 2011, 24 : 288A - 288A
  • [36] Combination activity of acalabrutinib and capivasertib in diffuse large B-cell lymphoma.
    Burke, Kathleen
    Roderick-Richardson, Justine
    Narang, Natasha
    Willis, Brandon
    Dry, Hannah
    Castriotta, Lillian
    Rosen, Alan
    Mettetal, Jay
    Barry, Simon
    Bloecher, Andrew
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Characteristics of Refractory and Relapsing Patients with Diffuse Large B-Cell Lymphoma.
    Coiffier, Bertrand
    Salles, Gilles
    Bosly, Andre
    Gaulard, Philippe
    Haioun, Corinne
    Casasnovas, Olivier
    Mounier, Nicolas
    Delfau, Marie Helene
    Sebban, Catherine
    Feugier, Pierre
    Recher, Christian
    Delarue, Richard
    Ketterer, Nicolas
    Tilly, Herve
    Gisselbrecht, Christian
    BLOOD, 2008, 112 (11) : 897 - 898
  • [38] Non-diffuse Large B-cell Lymphoma. Case Presentation
    Serra Valdes, Miguel Angel
    Borrego Moreno, Yasniel
    Viera Garcia, Marleny
    FINLAY, 2019, 9 (03): : 226 - 231
  • [39] Recurrent Endobronchial Diffuse Large B-cell Lymphoma. Diagnosed by Cryoprobe
    Pajares, Virginia
    Torrego, Alfons
    Granell, Miquel
    Szafranska, Justyna
    Mozos, Anna
    Puzo, Carmen
    ARCHIVOS DE BRONCONEUMOLOGIA, 2013, 49 (05): : 210 - 212
  • [40] Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma
    Rong, Yi
    Wang, Ming
    Ma, Yaqiong
    Liang, Yuanchen
    Ye, Lvyin
    Guo, Lin
    Lu, Renquan
    Wang, Yanchun
    MICROBIOLOGY SPECTRUM, 2025,
12345